Acadia Healthcare Company, Inc. current report, 06 May 2021

Acadia Healthcare Company, Inc. - Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K was filed by Acadia Healthcare Company, Inc. on May 7, 2021, regarding events occurring on May 6, 2021. The filing documents the results of the Company's 2021 Annual Meeting of Stockholders.

Key Financial Metrics

This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on corporate governance and shareholder voting outcomes.

Material Changes and Voting Results

At the Annual Meeting, stockholders approved several key proposals:

  • Director Elections: Three Class I directors were elected to serve until the 2024 annual meeting: E. Perot Bissell, Vicky B. Gregg, and Debra K. Osteen. All received significant majority support.
  • Compensation Plan Amendment: Stockholders approved an amendment to the Incentive Compensation Plan. This amendment increases the aggregate number of shares available for awards by 4,500,000.
  • Executive Compensation: The compensation of Named Executive Officers was approved on a non-binding advisory basis.
  • Auditor Ratification: Ernst & Young LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2021.

Guidance, Outlook, and Risks

The filing does not provide management commentary on future guidance, outlook, risks, contingencies, or unusual items. It serves strictly as a disclosure of the voting results and the amendment to the equity incentive plan.

Key Facts for Investor Verification

  • Verify the total number of shares authorized under the amended Incentive Compensation Plan by reviewing the definitive proxy statement filed on March 24, 2021.
  • Confirm the specific terms of the 4,500,000 share increase and any other changes to the Plan referenced in the proxy statement.
  • Note that the election of directors and ratification of the auditor were approved with overwhelming support, indicating strong shareholder alignment with current management and governance.